Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

QPT

Quest PharmaTech (QPT)

Quest PharmaTech Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:TSXV:QPT
DataHoraFonteTítuloCódigoCompanhia
30/01/202419:00PR Newswire (Canada)Quest Receives Cash Dividend Payment from OncoQuestTSXV:QPTQuest PharmaTech Inc
23/01/202419:49PR Newswire (Canada)Oregovomab Phase III Clinical Study fails futility analysis; Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical BenefitsTSXV:QPTQuest PharmaTech Inc
13/09/202317:15PR Newswire (Canada)Quest PharmaTech Provides Corporate UpdateTSXV:QPTQuest PharmaTech Inc
14/07/202317:30PR Newswire (Canada)Quest PharmaTech Announces Results from AGMTSXV:QPTQuest PharmaTech Inc
10/07/202317:30PR Newswire (Canada)Quest PharmaTech Provides Product Development UpdateTSXV:QPTQuest PharmaTech Inc
07/06/202308:52PR Newswire (Canada)L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - QPTTSXV:QPTQuest PharmaTech Inc
07/06/202308:50PR Newswire (Canada)Canadian Investment Regulatory Organization Trade Resumption - QPTTSXV:QPTQuest PharmaTech Inc
06/06/202318:15PR Newswire (Canada)Quest PharmaTech Clarifies Agreement in Principle with OQP Bio Inc.TSXV:QPTQuest PharmaTech Inc
06/06/202309:03PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - QPTTSXV:QPTQuest PharmaTech Inc
06/06/202309:00PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - QPTTSXV:QPTQuest PharmaTech Inc
28/09/202218:00PR Newswire (Canada)Quest PharmaTech Announces Sale of Bioceltran Investment and Return of Photodynamic Therapy Technology LicenseTSXV:QPTQuest PharmaTech Inc
01/09/202118:15PR Newswire (Canada)OncoQuest Pharmaceuticals Inc. Announces First Patient Enrolled in Each of Two Investigator Initiated Clinical Trials of Oregovomab in Combination Therapy for the Treatment of Recurrent Ovarian CancerTSXV:QPTQuest PharmaTech Inc
01/06/202116:00PR Newswire (Canada)Quest PharmaTech announces two presentations by OncoQuest Pharmaceuticals, Inc. at the 2021 Annual Meeting of the American As...TSXV:QPTQuest PharmaTech Inc
26/03/202120:14PR Newswire (Canada)Quest Provides Update to Immunotherapy Asset Transfer Between OncoQuest Inc. and OncoQuest Pharmaceuticals Inc.TSXV:QPTQuest PharmaTech Inc
09/11/202019:30PR Newswire (Canada)Quest Announces that OncoQuest Pharmaceuticals Inc. Doses First Patient in Phase 3 Clinical Trial, FLORA-5, of Company's Lead...TSXV:QPTQuest PharmaTech Inc
04/06/202018:05PR Newswire (Canada)Quest Provides Corporate UpdateTSXV:QPTQuest PharmaTech Inc
02/06/202017:11PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - QPTTSXV:QPTQuest PharmaTech Inc
02/06/202017:08PR Newswire (Canada)IIROC Trading Resumption - QPTTSXV:QPTQuest PharmaTech Inc
04/05/202012:16PR Newswire (Canada)MISE À JOUR - Suspension de la négociation par l'OCRCVM - QPTTSXV:QPTQuest PharmaTech Inc
04/05/202012:10PR Newswire (Canada)UPDATE - IIROC Trading Halt - QPTTSXV:QPTQuest PharmaTech Inc
01/05/202017:30PR Newswire (Canada)Quest PharmaTech Announces Results from its April 28, 2020 AGMTSXV:QPTQuest PharmaTech Inc
22/04/202014:10PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - QPTTSXV:QPTQuest PharmaTech Inc
22/04/202014:07PR Newswire (Canada)IIROC Trading Halt - QPTTSXV:QPTQuest PharmaTech Inc
22/04/202013:47PR Newswire (Canada)OncoQuest Signs a Definitive Agreement to Sell Drug Portfolio to Dual Industrial for U.S. $300 Million and Commitment to Fund...TSXV:QPTQuest PharmaTech Inc
24/03/202007:00PR Newswire (Canada)OncoQuest Announces Publication of Two Reports Related to Oregovomab Phase 2 Clinical Trial, the Company's Lead Investigation...TSXV:QPTQuest PharmaTech Inc
13/03/202018:01PR Newswire (Canada)OncoQuest Announces a U.S.$50 Million Investment by KOSDAQ listed Dual Industrial Co. Ltd.TSXV:QPTQuest PharmaTech Inc
25/09/201908:00PR Newswire (Canada)OncoQuest Receives "Notice of Allowance" for Patent Protection of the Administration Schedule of Oregovomab and Chemotherapy ...TSXV:QPTQuest PharmaTech Inc
25/01/201915:50PR Newswire (Canada)OncoQuest Lays the Groundwork for Commencement of Phase 3 Study in Frontline Ovarian CancerTSXV:QPTQuest PharmaTech Inc
19/12/201822:26PR Newswire (Canada)Quest PharmaTech Adopts Amendment to By-laws Requiring Advance Notice of Nomination of DirectorsTSXV:QPTQuest PharmaTech Inc
03/12/201816:25PR Newswire (Canada)Quest PharmaTech Announces Adoption of Shareholder Rights PlanTSXV:QPTQuest PharmaTech Inc
 Apresentando as notícias mais relevantes sobre:TSXV:QPT